The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Blog
Public
Hospital and health system leaders are navigating workforce shortages, reimbursement pressures, caring for a sicker patient population and rising operational…
Headline
The Ohio Hospital Association announced Aug. 19 that Sean McGlone, OHA senior vice president and general counsel, will be its next president and CEO effective…
Perspective
Public
The record-breaking number of Americans who followed the 2026 FIFA Men’s World Cup were treated to many memorable highlights, courtesy of a blend of skill and…
Perspective
Public
The Greek philosopher Heraclitus gets the credit for observing that “the only constant in life is change.” Yet it is something we all know is true because we…
Headline
The National Center for Healthcare Leadership July 14 announced that Michelle Hood, AHA executive vice president and COO, is the recipient of NCHL's 2026 Gail…
Headline
The AHA Board of Trustees Board of Trustees has elected Laura Kaiser, president and CEO of SSM Health, based in St. Louis, Mo., as its chair-…